Month: November 2018

Mapping & driving the stem cell ecosystem: key points of my new paper

stem-cell-ecosystem

When you think of an ecosystem, do you imagine something like a forest or jungle full of different organisms? I usually do, but over the last few years I’ve also been thinking about this concept in a different way. I’ve been viewing the broad stem cell arena as an ecosystem. In that spirit, I’ve recently …

Mapping & driving the stem cell ecosystem: key points of my new paper Read More »

Magenta Therapeutics Good News-Bad News Trial Data

Magenta

Magenta Therapeutics is a biotech company with a portfolio including stem cell products. Their most well known investigational drug product is an expanded umbilical cord stem cell product called MGTA-456, an “ex-Novartis” product. Magenta just released new trial data on MGTA-456, which I see as a case of good news-bad news, and investors seem to …

Magenta Therapeutics Good News-Bad News Trial Data Read More »